IRCT20200105046010N69招募中未知
In- Vivo Bioequivalence study of Oxycodone ER tablets 40 mg Alborz Pharmed with brand drugs (OLBETE® ER. 40 mg, Purdue Pharma LP, UK) in Iranian healthy volunteers.
Alborz Pharmed Pharmaceutical Co.0 个研究点目标入组 24 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 发起方
- 入组人数
- 24
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 years 至 55 years（—）
- 性别
- All
入选标准
- •General health
- •Body mass index between18-28
- •Informed consent
- •Being at the age of 18-55 years old
排除标准
- •A history of cardiovascular disease
- •A history of liver & kidney disease
- •Alcohol & Drug addiction
- •Hypersensitivity to the drug
研究者
相似试验
尚未招募
不适用
In-vivo Bioequivalence Test of FAROXY® tablet with brand OXYCONTIN drugs (Purdue Pharma LP, UKIn this study, the disease is not examined. Subject bioequivalence test and reference tablets OXYCONTIN studied.IRCT20200105046010N32Pharan shimi Pharmaceutical Company24
进行中（未招募）
1 期
En sammenlignende undersøgelse af iv. oxycodon og iv. fentanyl i behandlingen af postoperative smerter efter laparoskopisk cholecystektomi.EUCTR2006-003267-31-DKDepartment of anesthesiology80
已完成
1 期
A Study to Determine the Fasting Bioequivalence of Reformulated OXY Tablets and Original OxyContin® (OXY) TabletsHealthyNCT01101191Purdue Pharma LP84
已完成
1 期
To Determine the Fed Bioequivalence of Reformulated OXY Tablets and Original OxyContin® (OXY) TabletsHealthyNCT01101178Purdue Pharma LP79
已完成
1 期
A Study to Determine the Fed Bioequivalence of Reformulated OXY Tablets and Original OxyContin® (OXY) TabletsHealthy VolunteersNCT01099709Purdue Pharma LP85